125 related articles for article (PubMed ID: 24418300)
1. Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.
Terrier B; Marie I; Launay D; Lacraz A; Belenotti P; de Saint-Martin L; Quemeneur T; Huart A; Bonnet F; Le Guenno G; Kahn JE; Hinschberger O; Rullier P; Diot E; Lazaro E; Bridoux F; Zénone T; Carrat F; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
Autoimmun Rev; 2014 Jun; 13(6):630-4. PubMed ID: 24418300
[TBL] [Abstract][Full Text] [Related]
2. Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.
Terrier B; Marie I; Lacraz A; Belenotti P; Bonnet F; Chiche L; Graffin B; Hot A; Kahn JE; Michel C; Quemeneur T; de Saint-Martin L; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
J Autoimmun; 2015 Dec; 65():74-81. PubMed ID: 26320984
[TBL] [Abstract][Full Text] [Related]
3. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis.
Cacoub P; Si Ahmed SN; Ferfar Y; Pol S; Thabut D; Hezode C; Alric L; Comarmond C; Ragab G; Quartuccio L; Hegazy M; Poynard T; Resche Rigon M; Saadoun D
Clin Gastroenterol Hepatol; 2019 Feb; 17(3):518-526. PubMed ID: 29857143
[TBL] [Abstract][Full Text] [Related]
4. Relapse of Hepatitis C Virus Cryoglobulinemic Vasculitis After Sustained Viral Response After Interferon-Free Direct-Acting Antivirals.
Fayed A; Hegazy MT; Biard L; Vieira M; El Shabony T; Saadoun D; Casato M; Visentini M; Ragab G; Cacoub P
Am J Gastroenterol; 2022 Apr; 117(4):627-636. PubMed ID: 35103020
[TBL] [Abstract][Full Text] [Related]
5. Cryoglobulinemia Vasculitis.
Cacoub P; Comarmond C; Domont F; Savey L; Saadoun D
Am J Med; 2015 Sep; 128(9):950-5. PubMed ID: 25837517
[TBL] [Abstract][Full Text] [Related]
6. Non-infectious cryoglobulinemia vasculitis (CryoVas): update on clinical and therapeutic approach.
Perez-Alamino R; Espinoza LR
Curr Rheumatol Rep; 2014 May; 16(5):420. PubMed ID: 24647999
[TBL] [Abstract][Full Text] [Related]
7. Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey.
Terrier B; Krastinova E; Marie I; Launay D; Lacraz A; Belenotti P; de Saint-Martin L; Quemeneur T; Huart A; Bonnet F; Le Guenno G; Kahn JE; Hinschberger O; Rullier P; Diot E; Lazaro E; Bridoux F; Zénone T; Carrat F; Hermine O; Léger JM; Mariette X; Senet P; Plaisier E; Cacoub P
Blood; 2012 Jun; 119(25):5996-6004. PubMed ID: 22474249
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.
Terrier B; Karras A; Kahn JE; Le Guenno G; Marie I; Benarous L; Lacraz A; Diot E; Hermine O; de Saint-Martin L; Cathébras P; Leblond V; Modiano P; Léger JM; Mariette X; Senet P; Plaisier E; Saadoun D; Cacoub P
Medicine (Baltimore); 2013 Mar; 92(2):61-68. PubMed ID: 23429354
[TBL] [Abstract][Full Text] [Related]
9. Cryoglobulinemia vasculitis: an update.
Terrier B; Cacoub P
Curr Opin Rheumatol; 2013 Jan; 25(1):10-8. PubMed ID: 23196322
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of rituximab in nonviral cryoglobulinemia vasculitis: data from the French Autoimmunity and Rituximab registry.
Terrier B; Launay D; Kaplanski G; Hot A; Larroche C; Cathébras P; Combe B; de Jaureguiberry JP; Meyer O; Schaeverbeke T; Somogyi A; Tricot L; Zénone T; Ravaud P; Gottenberg JE; Mariette X; Cacoub P
Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1787-95. PubMed ID: 20740617
[TBL] [Abstract][Full Text] [Related]
11. Rituximab plus belimumab in non-infectious refractory cryoglobulinemia vasculitis: A pilot study.
Saadoun D; Ghembaza A; Riviere S; Mekinian A; Boutemy J; Leroux G; Domont F; Maillard H; Vautier M; Cacoub P
J Autoimmun; 2021 Jan; 116():102577. PubMed ID: 33248866
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for relapse in non-infectious cryoglobulinemic vasculitis, including type I cryoglobulinemia: a systematic review.
Rajendran N; Rameli PM; Awad H
Front Immunol; 2023; 14():1215345. PubMed ID: 37483620
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.
Terrier B; Carrat F; Krastinova E; Marie I; Launay D; Lacraz A; Belenotti P; de Saint Martin L; Quemeneur T; Huart A; Bonnet F; Le Guenno G; Kahn JE; Hinschberger O; Rullier P; Hummel A; Diot E; Pagnoux C; Lzaro E; Bridoux F; Zenone T; Hermine O; Leger JM; Mariette X; Senet P; Plaisier E; Cacoub P
Ann Rheum Dis; 2013 Mar; 72(3):374-80. PubMed ID: 22586172
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis.
Colantuono S; Mitrevski M; Yang B; Tola J; Carlesimo M; De Sanctis GM; Fiorilli M; Casato M; Visentini M
Clin Rheumatol; 2017 Mar; 36(3):617-623. PubMed ID: 28111716
[TBL] [Abstract][Full Text] [Related]
15. Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature.
Pouchelon C; Visentini M; Emmi G; le Guern V; Quartuccio L; Samson M; Venhoff N; Briantais A; Casato M; Chatelus E; Chilles M; Cid MC; Diot E; Ebbo M; Faguer S; Hellmich B; Jachiet M; Moulinet T; Perrin F; Quémeneur T; Sinico RA; Terrier B
Autoimmun Rev; 2022 Apr; 21(4):103034. PubMed ID: 34995764
[TBL] [Abstract][Full Text] [Related]
16. Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis.
Terrier B; Karras A; Cluzel P; Collet JP; Sène D; Saadoun D; Cacoub P
Am J Cardiol; 2013 Jan; 111(2):265-72. PubMed ID: 23116612
[TBL] [Abstract][Full Text] [Related]
17. Correlation of clinical and virologic responses to antiviral treatment and regulatory T cell evolution in patients with hepatitis C virus-induced mixed cryoglobulinemia vasculitis.
Landau DA; Rosenzwajg M; Saadoun D; Trébeden-Negre H; Klatzmann D; Cacoub P
Arthritis Rheum; 2008 Sep; 58(9):2897-907. PubMed ID: 18759287
[TBL] [Abstract][Full Text] [Related]
18. Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.
Quartuccio L; Zuliani F; Corazza L; Scaini P; Zani R; Lenzi M; Tavoni A; Sebastiani M; Baldovino S; Urraro T; Saccardo F; Sbreglia C; Mazzaro C; Pioltelli P; Fraticelli P; Filippini D; Gabrielli A; Perrella O; Scarpato S; Roccatello D; Zignego AL; Ferri C; Bombardieri S; Pietrogrande M; Monti G; Galli M; De Vita S
J Autoimmun; 2015 Sep; 63():88-93. PubMed ID: 26255249
[TBL] [Abstract][Full Text] [Related]
19. Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patients.
Roubertou Y; Mainbourg S; Hot A; Fouque D; Confavreux C; Chapurlat R; Debarbieux S; Jullien D; Sève P; Juillard L; Kolopp-Sarda MN; Lega JC
Arthritis Res Ther; 2022 Jul; 24(1):167. PubMed ID: 35836280
[TBL] [Abstract][Full Text] [Related]
20. Using rituximab plus fludarabine and cyclophosphamide as a treatment for refractory mixed cryoglobulinemia associated with lymphoma.
Saadoun D; Pineton de Chambrun M; Hermine O; Karras A; Choquet S; Jego P; Decaux O; Cacoub P
Arthritis Care Res (Hoboken); 2013 Apr; 65(4):643-7. PubMed ID: 22972527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
